Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Environ Sci Pollut Res Int ; 28(16): 19539-19542, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33723786

RESUMO

Pollution and pollution-related consequences have a historic reputation, being even considered as chief causative agents behind several tragedies linked to a huge impact on health and environment. Nonetheless, the unforeseen viral outburst has surprisingly led to the recovery of the atmospheric immaculacy, besides to the serious destruction. Thus, here some important aspects related to the impact of pollution on the viral epidemic and vice versa were attempted to be critically discussed.


Assuntos
Poluição do Ar , COVID-19 , Poluição do Ar/análise , Poluição Ambiental , Humanos , Índia , SARS-CoV-2
2.
Life Sci ; 271: 119182, 2021 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-33577851

RESUMO

Glitazones are synthetic derivatives of thiazolidinedione, and are designated as oral anti-diabetic agents, primarily acting on peroxisome proliferator-activated receptor-gamma (PPAR-γ) receptors and driving some crucial metabolic pathways linked to glucose and lipid metabolism at transcriptional level. Despite presenting adverse effects, including weight gain, fluid retention, prostate hyperplasia, hyperinsulinemia, and myocardial infarction, they are still preferred in clinical settings due to their utmost efficacy and selectivity. However, these complications kept glitazones restrained for long-term usage. The present review briefly highlights some important synthetic derivatives of thiazolidine2,4-dione and emphasizes the influence of various structural manipulations on their bio-efficacy.


Assuntos
Hipoglicemiantes/química , Hipoglicemiantes/metabolismo , Tiazolidinedionas/química , Tiazolidinedionas/metabolismo , Animais , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Glucose/antagonistas & inibidores , Glucose/metabolismo , Humanos , Hipoglicemiantes/uso terapêutico , Resistência à Insulina/fisiologia , PPAR gama/metabolismo , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Tiazolidinedionas/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...